Detalles de la búsqueda
1.
Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing.
Pathol Int
; 74(2): 77-86, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38226479
2.
[Efficacy and Safety Analysis of Selpercatinib in Patients with RET Fusion-Positive Non-Small Cell Lung Cancer-Results from the Japanese Subset of a Global Phase 1/2 Study].
Gan To Kagaku Ryoho
; 49(6): 669-675, 2022 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-35799394
3.
A phase 1 study of crenigacestat (LY3039478), the Notch inhibitor, in Japanese patients with advanced solid tumors.
Invest New Drugs
; 39(2): 469-476, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32939607
4.
Clinical Impact of a Shortened Infusion Duration of Ramucirumab in Japanese Patients -A Model-Based Approach.
Gan To Kagaku Ryoho
; 48(11): 1381-1387, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34795131
5.
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcoma.
Cancer Sci
; 109(12): 3962-3970, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30353601
6.
A powerful test for Balaam's design.
Pharm Stat
; 14(6): 464-70, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26214841
7.
Latent class models for medical diagnostic tests in multicenter trials.
Stat Med
; 32(29): 5091-105, 2013 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24038422
8.
Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.
Breast Cancer
; 29(1): 174-184, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34661821
9.
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.
Breast Cancer
; 28(5): 1038-1050, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33797023
10.
Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer.
Cancer Chemother Pharmacol
; 78(2): 281-8, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27312735
11.
A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.
Dement Geriatr Cogn Dis Extra
; 1(1): 163-79, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22163242
Resultados
1 -
11
de 11
1
Próxima >
>>